Sign In
Buy HQY
$85.21
-3.13 (-3.54%)
At Close: Jun 03, 2026
HealthEquity Reports Record HSA Sales, Asset Growth
09:02pm, Tuesday, 22'nd Feb 2022 GlobeNewswire Inc.
Raises Revenue Outlook Raises Revenue Outlook
Abbott (ABT) Gets FDA Approval for CardioMEMS HF System
01:12pm, Tuesday, 22'nd Feb 2022 Zacks Investment Research
Abbott's (ABT) CardioMEMS HF System will enable physicians to monitor for early warning signs of worsening heart failure before it progresses to a later stage.
HealthEquity Q4 2022 Earnings Preview (NASDAQ:HQY)
10:35pm, Monday, 21'st Feb 2022 Seeking Alpha
HealthEquity (NASDAQ:HQY) is scheduled to announce Q4 earnings results on Tuesday, February 22nd, after market close.The consensus EPS Estimate is $0.21 (-50.0% Y/Y) and the
Here's Why You Should Hold on to STERIS (STE) Stock for Now
03:10pm, Monday, 21'st Feb 2022 Zacks Investment Research
Investors are optimistic about STERIS (STE) on its better-than-expected earnings in the fiscal third quarter and the ongoing integration of the Cantel Medical business.
Baron Funds: “HealthEquity (HQY) is Now Trading at a Reasonable Multiple of Lower Estimates”
03:13pm, Thursday, 17'th Feb 2022 Insider Monkey
Baron Funds, an asset management firm, published its “Baron Small Cap Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here.
Here's Why You Should Hold on to IDEXX (IDXX) Stock for Now
01:18pm, Thursday, 17'th Feb 2022 Zacks Investment Research
Robust domestic and international performances by the CAG arm are driving IDEXX's (IDXX) fourth-quarter top line.
Tandem Diabetes (TNDM) to Offer Insulin Delivery With Smartphone
01:16pm, Thursday, 17'th Feb 2022 Zacks Investment Research
Tandem Diabetes' (TNDM) t:connect is the first-ever app on both iOS and Android operating systems to receive FDA clearance for insulin delivery from a personal smartphone.
OPKO's (OPK) NGENLA to Offer GHD Treatment in European Union
04:07pm, Wednesday, 16'th Feb 2022 Zacks Investment Research
OPKO's (OPK) marketing authorization for NGENLA in the European Union stands to benefit children and adolescents affected by growth hormone deficiency.
Are Brighter Times Ahead for HealthEquity Stock in 2022?
12:00pm, Wednesday, 16'th Feb 2022 The Motley Fool
The HSA specialist suffered during the pandemic, but the long-term trends for it still look favorable.
Are Brighter Times Ahead for HealthEquity Stock in 2022?
12:00pm, Wednesday, 16'th Feb 2022 The Motley Fool
The HSA specialist suffered during the pandemic, but the long-term trends for it still look favorable.
Here's Why You Should Hold on to Thermo Fisher (TMO) Stock Now
02:44pm, Tuesday, 15'th Feb 2022 Zacks Investment Research
Investors are optimistic about Thermo Fisher's (TMO) better-than-expected fourth-quarter results and impressive COVID-19 response-related revenues.
HealthEquity Recognized for Gender Equality and Workplace Inclusivity
02:01pm, Tuesday, 08'th Feb 2022 GlobeNewswire Inc.
Exceeds threshold for national and global equality index markers by Bloomberg and the Human Rights Campaign Foundation Exceeds threshold for national and global equality index markers by Bloomberg a
HealthEquity Announces Reporting Date of FY22 Sales Results Presentation at Conferences
09:06pm, Tuesday, 01'st Feb 2022 GlobeNewswire Inc.
DRAPER, Utah, Feb. 01, 2022 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest independent health savings account (“HSA") custod
Why HealthEquity Stock Was Winning Big This Week
03:22am, Friday, 14'th Jan 2022 The Motley Fool
The company unveiled some highly encouraging growth statistics.
Why HealthEquity Stock Was Winning Big This Week
03:22am, Friday, 14'th Jan 2022 The Motley Fool
The company unveiled some highly encouraging growth statistics.
